Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Discover Financial Services, Reports 7.6% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, disclosing a 7.6% beneficial ownership stake in Discover Financial Services as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.0% Stake in Cadence Design Systems
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 8.0% of Cadence Design Systems Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.1% Passive Stake in Ducommun Inc.
BlackRock, Inc. has filed an Amendment No. 11 to Schedule 13G, reporting a beneficial ownership of 8.1% of Ducommun Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Stake in Sierra Bancorp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership stake in Sierra Bancorp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.5% beneficial ownership stake in Skyworks Solutions Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Tactile Systems Technology, Disclosing 7.7% Passive Ownership
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, revealing a 7.7% passive beneficial ownership stake in Tactile Systems Technology Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an updated Schedule 13G, disclosing a 7.4% beneficial ownership stake in Tarsus Pharmaceuticals, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.8% beneficial ownership stake in Teladoc Health Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Significant Stake in Trex Company Inc., Maintaining 9.8% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 18 to its Schedule 13G, disclosing a 9.8% beneficial ownership stake in Trex Company Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 5.4% Passive Stake in TScan Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.4% passive beneficial ownership stake in TScan Therapeutics, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Schedule 13G, Disclosing 7.6% Passive Stake in Turning Point Brands
BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, reporting a 7.6% passive beneficial ownership stake in Turning Point Brands, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 5.1% beneficial ownership stake in Ultragenyx Pharmaceutical Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.3% Passive Stake in Valero Energy Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.3% beneficial ownership stake in Valero Energy Corp as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 6.4% Passive Stake in Voyager Therapeutics
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.4% beneficial ownership stake in Voyager Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 9.5% beneficial ownership stake in Welltower Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.1% Stake in Workiva Inc. Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 8.1% of Workiva Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing its beneficial ownership of 9.1% of YETI Holdings Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, disclosing a 6.9% beneficial ownership stake in Acushnet Holdings Corp.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.9% of Albertsons Companies, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, disclosing a 7.2% beneficial ownership stake in Amerant Bancorp Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 13.8% of ARMOUR RESIDENTIAL REIT INC's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Increases Stake in Astec Industries to 16.4%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 16.4% of Astec Industries Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amendment to its Schedule 13G, disclosing an 8.1% beneficial ownership stake in Avery Dennison Corporation as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 9.7% beneficial ownership stake in Paramount Group, Inc. as of March 31, 2025, held in the ordinary course of business.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 9.1% Stake in Planet Fitness Class A Stock
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 9.1% of Planet Fitness, Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 5.3% of PLAYSTUDIOS, Inc.'s Class A Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 7.8% Passive Stake in Primoris Services Corp
Investment giant BlackRock, Inc. has filed an amended Schedule 13G, revealing a 7.8% passive beneficial ownership stake in Primoris Services Corp as of March 31, 2025.
NYSE
BlackRock, Inc. has filed a Schedule 13G, revealing a passive ownership of 5.1% of Proficient Auto Logistics, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 8 to Schedule 13G, reporting a 7.8% beneficial ownership stake in PROS Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 13.7% Passive Stake in Qorvo, Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 13.7% of Qorvo, Inc.'s common stock as of March 31, 2025.